A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial.

MLA

Jemec, Gregor B. E., et al. “A New Scalp Formulation of Calcipotriene plus Betamethasone Compared with Its Active Ingredients and the Vehicle in the Treatment of Scalp Psoriasis: A Randomized, Double-Blind, Controlled Trial.” Journal of the American Academy of Dermatology, vol. 59, no. 3, Sept. 2008, pp. 455–63. EBSCOhost, https://doi.org/10.1016/j.jaad.2008.04.027.

APA

Jemec, G. B. E., Ganslandt, C., Ortonne, J.-P., Poulin, Y., Burden, A. D., de Unamuno, P., Berne, B., Figueiredo, A., & Austad, J. (2008). A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial. Journal of the American Academy of Dermatology, 59(3), 455–463. https://doi.org/10.1016/j.jaad.2008.04.027

Chicago

Jemec, Gregor B.E., Cecilia Ganslandt, Jean-Paul Ortonne, Yves Poulin, A. David Burden, Pablo de Unamuno, Berit Berne, Américo Figueiredo, and Joar Austad. 2008. “A New Scalp Formulation of Calcipotriene plus Betamethasone Compared with Its Active Ingredients and the Vehicle in the Treatment of Scalp Psoriasis: A Randomized, Double-Blind, Controlled Trial.” Journal of the American Academy of Dermatology 59 (3): 455–63. doi:10.1016/j.jaad.2008.04.027.